Moolec Science (MLEC) Exchange Rate Effect (2022 - 2024)
Moolec Science's (MLEC) quarterly Exchange Rate Effect came in at $786331.0 in Q4 2024, up 112.44% year-on-year from $370143.2 in Q1 2024, and up 24.21% quarter-over-quarter from $633051.0 in Q3 2024.
Moolec Science (MLEC) Exchange Rate Effect (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Exchange Rate Effect across 3 years of filings, most recently posting $786331.0 for Q4 2024.
- Exchange Rate Effect for Q4 2024 came in at $786331.0, up 112.44% year-over-year; the trailing twelve-month figure through Dec 2024 was $786331.0 (down 86.13% YoY), and the FY2025 annual result was -$4.9 million, down 3959.2% from the prior year.
- Exchange Rate Effect came in at $786331.0 for Q4 2024 at Moolec Science, up from $633051.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $6.9 million in Q2 2022 to a low of -$6.3 million in Q4 2023.
- The 3-year median for Exchange Rate Effect is $131204.5 (2023), against an average of $715364.2.
- Across the five-year window, Exchange Rate Effect jumped 13231.6% in 2023 and tumbled 135.07% in 2024, its largest moves.
- Moolec Science's Exchange Rate Effect stood at $6.9 million in 2022, then tumbled by 192.22% to -$6.3 million in 2023, then soared by 112.44% to $786331.0 in 2024.
- The last three Exchange Rate Effect figures came in at $786331.0 (Q4 2024), $633051.0 (Q3 2024), and $125709.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 8.68 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 786,331.00 |
| Dec 31, 2024 | 786,331.00 |
| Sep 30, 2024 | 633,051.00 |
| Sep 30, 2024 | 633,051.00 |
| Jun 30, 2024 | 125,709.00 |
| Jun 30, 2024 | 125,709.00 |
| Mar 31, 2024 | -47,940.00 |
| Mar 31, 2024 | -47,940.00 |
| Dec 31, 2023 | -6.32 Mn |
| Dec 31, 2023 | -6.32 Mn |
| Sep 30, 2023 | -12,564.00 |
| Sep 30, 2023 | -12,564.00 |
| Jun 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 5.00 Mn |
| Mar 31, 2023 | 136,700.00 |
| Mar 31, 2023 | 136,700.00 |
| Jun 30, 2022 | 6.85 Mn |
| Jun 30, 2022 | 6.85 Mn |
| Mar 31, 2022 | -1,041.00 |
| Mar 31, 2022 | -1,041.00 |